Home/ Supplements/ Omega 3/ Marine Ethyl-EPA 70%

Marine Ethyl-EPA 70%

product on market Capsule Igennus Healthcare Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This supplement provides eicosapentaenoic acid (EPA), an omega-3 fatty acid with strong evidence for supporting cardiovascular health and managing inflammation. The profile focuses on high-concentration EPA to support heart function. Research indicates these components are generally well-tolerated and safe for most adults.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Marine Ethyl-EPA 70%
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
29%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5.5 Kcal
Total Fat
498 mg
Protein
158 mg
Carbohydrates
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Gamma-Linolenic Acid
9 mg
1 mg TE (8.4% DV)
Within RDA (0.1× RDA) 179 studies (A:3, B:90)

Other Ingredients

Capsule Shell Ethyl-EPA Concentrate organic cold-pressed virgin Evening Primrose Oil Vitamin E
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use For general wellbeing: adults and children aged twelve years and over should take 2 glucosamine & Calcium capsules (blue blister) and 1 E-EPA 70 capsule (silver blister) daily For individuals who are especially active or those who require additional joint & bone support in later life: take 4 glucosamine & Calcium capsules (blue blister) and 2 E-EPA 70 capsules (silver blister) daily Take Omegaflex Duo with food for optimum absorption.

Warnings & Precautions

It is not advisable to exceed the above dose unless advised by a healthcare practitioner.

If taking any medication, seek professional medical advice before taking this product. If you are taking any mediation that thins the blood, do not take this product without prior medical advice.

This product should not be used as a substitute for a balanced diet.

Store in a cool, dry place away from direct sunlight and away from children.

Formulation Notes

Advanced multi-action joint & bone support

Marine Ethyl-EPA 70% with plant GLA Source of beneficial fatty acids & phytonutrients

Contains no artificial colours, flavours or preservatives.

Omegaflex Duo combines highly bioavailable glucosamine hydrochloride, calcium and other trace minerals derived from the marine Algas Calcareas with 70% ethyl-EPA concentrated from marine anchovy oil, and GLA and triterpenes from organic virgin evening primrose oil.

Ethyl-EPA derived from sustainable marine anchovies anchovies and certified free from PCBs, mercury & dioxins

Free from: dairy, gluten, lactose, shellfish, yeast Non-GMO

Not tested on animals

Additional Information

Replenish & protect

Store in a cool, dry place away from direct sunlight and away from children.

Supplementation may be helpful to correct nutrient deficiencies though it can never be a substitute for a healthy diet and active lifestyle, which play a crucial role in maintaining overall wellbeing.

Metadata

Product Details

DSLD Entry Date2021-07-27
Product TypeOther Combinations
FormCapsule
DSLD ID249520
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.